Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07701486RecruitingPhase 1/Phase 2
Testing more frequent VCN-01 with standard chemo for new pancreatic cancer
This study tests a more frequent schedule of the experimental drug VCN-01 along with standard chemotherapy (nab-paclitaxel and gemcitabine) for people newly diagnosed with pancreatic cancer that has spread. The goal is to see if the virus-based therapy can help shrink tumors better.
Madrid, MadridAges 18 years+ - NCT07383506RecruitingPhase 1
Study of a targeted pill for PIK3CA-mutated advanced cancers
This trial tests a new pill (CGT6297) that targets cancer cells with a specific PIK3CA gene change. It may be an option for people with certain advanced solid tumors, including endometrial or breast cancer, after standard treatments have stopped working.
Scottsdale, ArizonaAges 18 years+ - NCT07825480Recruiting
Walking program after back surgery for spinal stenosis
This study tests a walking and activity program for people recovering from back surgery for lumbar spinal stenosis. It aims to help you get moving safely after surgery to improve your recovery.
Boston, MassachusettsAges 40–85 - NCT06568939RecruitingPhase 2
Study of telisotuzumab vedotin for non-squamous lung cancer
This trial tests a drug called telisotuzumab vedotin (ABBV-399) given through a vein to people with a specific type of advanced lung cancer (non-squamous non-small cell lung cancer) that has a high level of a protein called c-Met. The study aims to see how the drug affects the body and helps control the cancer.
Chandler, ArizonaAges 18 years+ - NCT07066709RecruitingPhase 2
Hip pain study after hip surgery
This study tests if a second hip surgery can help people who still have pain at least 6 months after their first hip surgery. It may help you if you have ongoing hip pain and haven't needed strong pain pills.
Madison, WisconsinAges 18–45 - NCT06759389Recruiting
Ventor study for cardiac arrest outside the hospital
This trial is testing a new device or procedure for adults who have a cardiac arrest outside the hospital. It aims to see if it can help improve outcomes for patients like you.
Stony Brook, New YorkAges 18–75 - NCT07585890Recruiting
Liver Transplant Outcomes With Machine Preservation in Europe
This study collects information about how livers do after transplantation when they've been preserved using machine perfusion—a technique that keeps donor livers in better condition before surgery. Researchers want to understand which preservation methods work best to improve transplant success across Europe.
InnsbruckAges 18 years+ - NCT07753252RecruitingPhase 1
How a new drug affects metformin levels in healthy adults
This study tests a new drug called sevabertinib to see if it changes how the body handles metformin, a common diabetes medicine. It is for healthy adults and will help researchers understand if the two drugs can be taken together safely.
Miami, FloridaAges 18–55 - NCT06519734Recruiting
Immune Deficiency, IUDs and Menstrual Products Study
This study looks at how well women with primary immune deficiencies can use intrauterine devices (IUDs) and other menstrual products. It aims to help doctors and patients make better choices for safe and effective period care.
ParisAges 18 years+ - NCT07421167RecruitingPhase 2
Ianalumab with TPO-RA for immune thrombocytopenia
This trial tests a new drug called ianalumab combined with a standard platelet-boosting medicine (TPO-RA) for adults with immune thrombocytopenia (ITP) or Evans syndrome. The goal is to see if the combination is well-tolerated and helps raise platelet counts.
Chandler, ArizonaAges 18 years+ - NCT07807241RecruitingPhase 1
Study of MX006 for advanced tumors with B7-H3
This trial tests a new drug (MX006) in people with advanced or metastatic tumors that have a specific marker called B7-H3. The drug may work by targeting this marker to stop cancer growth. The study aims to see if MX006 is safe and effective in this patient group.
Sarasota, FloridaAges 18 years+ - NCT07526766Recruiting
Exercise Program for Heart Artery Dissection and Fibromuscular Dysplasia
This study tests whether a supervised exercise program is safe and helpful for people who have had a spontaneous tear in a heart artery (SCAD) or fibromuscular dysplasia (a condition affecting blood vessel walls). The goal is to see if exercise can improve heart health after recovery from these conditions.
Jacksonville, FloridaAges 21–65 - NCT07821450Recruiting
Eyelid drooping after repeated eye injections
This study checks if repeated anti-VEGF eye injections, used to treat retinal diseases, can cause the upper eyelid to droop. It follows people getting their first injection in one eye and watches for eyelid changes.
IstanbulAges 18 years+ - NCT07821944RecruitingPhase 3
A new daily pill for lowering cholesterol in adults at high risk
This study tests a new daily pill called enlicitide that lowers bad cholesterol in adults at high risk for heart problems. If you have high cholesterol despite being on a statin, this trial could help you manage your cholesterol and reduce your risk of heart attacks or strokes.
Belagavi, KarnatakaAges 18 years+ - NCT05765851RecruitingPhase 1
A study of a new drug for advanced solid tumors with HER2
This trial tests a new combination treatment for people with advanced solid tumors that have HER2 changes. The goal is to see if it can shrink tumors or slow growth.
Sarasota, FloridaAges 18 years+ - NCT05903235Recruiting
VR and mirror therapy for arm recovery after stroke
This trial tests a mix of virtual reality (VR) and mirror therapy to help improve arm movement after a stroke. You may be asked to use the technology and give feedback, and the study may compare it with other care approaches to see if it helps more.
Taoyuan CityAges 20–80 - NCT07248410Recruiting
Laser treatment with and without exosomes for male hair loss
This trial tests whether adding exosomes (tiny cell-repair particles) to a fractional laser treatment helps regrow hair more effectively than laser alone in men with common pattern baldness. If you qualify, you'll receive treatment on part of your scalp while doctors compare both approaches.
Taoyuan, TaoyuanAges 18–50 - NCT07770685RecruitingPhase 1/Phase 2
Study of a new eye drop for advanced glaucoma
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Boston, MassachusettsAges 18 years+ - NCT05320198RecruitingPhase 1/Phase 2
Testing DISC-0974 for anemia in myelofibrosis or MDS
This trial tests an investigational drug called DISC-0974 for people with myelofibrosis or certain types of MDS who have low red blood cell counts (anemia). The goal is to see if this treatment can help improve anemia and reduce the need for blood transfusions.
Gilbert, ArizonaAges 18 years+ - NCT07622342RecruitingPhase 2
Study of a new injection for myasthenia gravis
This trial tests an investigational drug called SHR-2173, given as an injection, for people with generalized myasthenia gravis. It aims to see if the drug can improve muscle strength and daily function.
Changsha, HunanAges 18–75 - NCT05961176Recruiting
Electronic shirt to monitor heart and breathing in children in the ICU
This trial tests a special electronic shirt that can monitor heart rate, breathing, and other vital signs in children admitted to the intensive care unit. The goal is to see if this shirt works well for continuous monitoring, which might make care more comfortable and safer for children.
Toronto, OntarioAges 1 month–12 years - NCT06069518Recruiting
Continuous glucose monitoring for diabetes in peritoneal dialysis
This study tests whether using a continuous glucose monitor (a small device that checks blood sugar constantly) can help people with diabetes who are on peritoneal dialysis manage their blood sugar better. It might give a clearer picture of glucose levels than finger-prick tests alone.
Mexico City, Mexico CityAges 40–70 - NCT06697197RecruitingPhase 1/Phase 2
Study of BMS-986482 alone or with other drugs for advanced solid tumors
This trial tests a new drug, BMS-986482, given alone or in combination with other treatments, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it can shrink tumors or slow their growth.
Irvine, CaliforniaAges 18 years+ - NCT07886268RecruitingPhase 2
Study of TP-06 for persistent corneal defects
This trial tests an experimental eye drop called TP-06 to see if it helps heal persistent corneal defects (areas of the eye's surface that won't close) that haven't improved with standard treatment.
Scottsdale, ArizonaAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.